Concepedia

Mohammed Azharuddin

MA

Statistics

Publications

9

Citations

2.1K

H-Index

9

Active since

2005

Affiliations

University of Oxford(Current)

Glasgow Royal Infirmary

University of Nottingham

King's College London

University of Cambridge

Mohammed Azharuddin is an author at University of Oxford specializing in medicine, covid-19, and clinical trials.

Top concepts

MedicineCovid-19GeneticsPathologyProteomicsAntibioticsHuman GrowthEndocrinologyCell SignalingClinical Trials

Publications per year

2005–2023

9

Publications

9

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 555 citations · Full text

Long Covid, Antimicrobial Stewardship, Antibiotics +7

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 382 citations · Full text

Covid-19 Pandemic, Antiviral Therapy, Clinical Trials +3

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 289 citations · Full text

Mutant Prolactin Receptor and Familial Hyperprolactinemia

Paul Newey, Caroline M. Gorvin, Stephen J. Cleland et al. · New England Journal of Medicine · 2013 · 130 citations · Full text

Human Growth, Genetics, Janus Kinase 2 +18

Rows per page

1–5 of 9